(Q36330921)

English

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

0 references

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Hertzel C. Gerstein

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

2

object named as

Hisatomi Arima

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

6

object named as

Peter Reaven

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

9

object named as

Ruth L Coleman

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Mark Woodward

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Rodney A Hayward

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Timothy Craven

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Collaborators on Trials of Lowering Glucose (CONTROL) group

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

29 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

431-437

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Changes in diabetes-related complications in the United States, 1990-2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Need for better diabetes treatment for improved renal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(17)30104-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36330921&oldid=1833576854"